7 Gout Myths That Are Keeping Americans in Unnecessary Pain

Gout is one of the oldest documented diseases in human history, yet it remains one of the most misunderstood conditions in modern America. Approximately 9.2 million adults in the United States live with gout, yet misinformation about the disease circulates freely — on social media feeds, in workplace conversations, and even within families. The consequences of this misinformation are not trivial. Delayed diagnoses, abandoned treatment plans, and preventable flares are the real-world outcomes when myths go unchallenged.

Below, we address seven of the most persistent and damaging misconceptions about gout, replacing each with what the clinical evidence actually shows.

Myth 1: Gout Only Affects Older Men Who Eat Too Much

This stereotype is perhaps the most culturally entrenched of all gout myths. The image of a rotund, elderly gentleman with a bandaged foot propped on a cushion has been a fixture in Western art and literature for centuries. While gout does disproportionately affect men and tends to increase in prevalence with age, the disease is not confined to this demographic.

Women develop gout too — particularly after menopause, when estrogen levels drop and the kidneys become less efficient at excreting uric acid. Younger adults, including people in their 20s and 30s, are increasingly diagnosed with gout, a trend researchers attribute to rising rates of obesity, hypertension, and metabolic syndrome in younger age groups. Gout does not discriminate based on lifestyle alone, and reducing it to a caricature causes real people to dismiss symptoms that deserve medical attention.

Myth 2: Changing Your Diet Alone Will Cure Gout

Diet plays a meaningful role in gout management — there is no question about that. Reducing consumption of purine-rich foods such as red meat, shellfish, and organ meats, limiting alcohol intake, and staying well hydrated can all help lower uric acid levels and reduce flare frequency. However, dietary modification is not a cure.

For the majority of gout patients, elevated uric acid is substantially driven by genetics and kidney function, not diet alone. Studies suggest that dietary changes typically reduce serum uric acid by approximately 1 mg/dL — a modest improvement in many cases, but rarely sufficient to bring levels into a safe range without pharmacological support. Patients who rely exclusively on dietary changes may feel they are doing everything right while still experiencing flares, leading to frustration and eroded confidence in their own ability to manage the condition.

Myth 3: If You're Not in Pain, Your Gout Is Gone

Gout flares are episodic by nature, which creates a dangerous illusion: the absence of pain feels like the absence of disease. Between flares, patients often feel completely normal, and it is tempting to conclude that the gout has resolved on its own.

In reality, uric acid crystals continue to accumulate in joints, tendons, and surrounding tissue during pain-free intervals. Without treatment to lower uric acid levels, each subsequent flare is likely to be more severe, last longer, and affect additional joints. Over time, untreated gout can progress to a chronic condition characterized by persistent joint damage and the formation of tophi — deposits of crystallized uric acid visible beneath the skin. Feeling fine between attacks is not a green light to stop treatment; it is an opportunity to get ahead of the disease.

Myth 4: Colchicine Is Too Dangerous to Take Regularly

Colchicine has a long history that predates modern pharmacology, and some patients encounter alarming information online about its toxicity. While it is true that colchicine requires careful dosing and can interact with certain medications, characterizing it as universally dangerous misrepresents how it is used in contemporary clinical practice.

When prescribed and monitored appropriately, colchicine is a well-tolerated and highly effective medication for both treating acute gout flares and preventing future ones. The low-dose regimens currently recommended by US clinical guidelines have a substantially improved safety profile compared to the higher doses used decades ago. Patients who avoid colchicine based on fear — rather than a specific medical contraindication — may be forgoing one of the most effective tools available for controlling their condition.

Myth 5: Drinking Cherry Juice Will Lower Your Uric Acid Enough to Matter

Cherry juice and cherry extract have attracted significant attention in gout communities, and some research does suggest that tart cherries contain compounds with anti-inflammatory properties. A handful of small studies have shown modest associations between cherry consumption and reduced flare frequency.

However, the evidence base is limited, and cherry juice is not a validated substitute for urate-lowering therapy in patients with established gout. For individuals whose uric acid levels remain elevated despite dietary modifications, cherries are unlikely to close the gap. There is nothing wrong with including cherries as part of a healthy diet, but patients should be cautious about replacing evidence-based treatment with nutritional remedies that have not been rigorously tested in large clinical trials.

Myth 6: Gout Is a Standalone Problem — Not Connected to Other Health Conditions

Many Americans think of gout as an isolated joint problem — inconvenient and painful, but not connected to anything more serious. This perspective misses a critical dimension of the disease.

Gout is strongly associated with a cluster of metabolic and cardiovascular conditions, including hypertension, type 2 diabetes, chronic kidney disease, and coronary artery disease. Elevated uric acid itself has been studied as a potential contributor to cardiovascular risk, though the causal relationship remains an active area of research. Patients with gout are statistically more likely to experience cardiovascular events than those without it, which is why comprehensive gout management often involves addressing the full spectrum of metabolic health — not just joint pain.

Myth 7: You Should Wait Until a Flare Is at Its Worst Before Treating It

Some patients delay treatment at the first sign of a gout flare, either hoping it will resolve on its own or waiting until the pain becomes severe enough to feel justified in taking medication. This approach consistently produces worse outcomes.

Clinical guidelines in the United States are explicit on this point: colchicine and other anti-inflammatory treatments are most effective when initiated as early as possible — ideally within the first 12 to 24 hours of symptom onset. Waiting allows the inflammatory cascade to intensify, making the flare harder to control and extending its duration. Patients who keep a physician-approved treatment plan on hand and act quickly at the first warning signs — often a subtle warmth or tingling in the affected joint — consistently report shorter, less severe episodes.

The Cost of Believing the Wrong Information

Misinformation about gout is not harmless. Every myth on this list has contributed to delayed treatment, abandoned medication regimens, or a diminished quality of life for real patients across the country. The antidote is straightforward: access to accurate, evidence-based information and a trusting relationship with a healthcare provider who understands the full complexity of this disease.

Gout is manageable. For many patients, it is possible to reach a state where flares become rare or cease entirely. But that outcome depends on replacing myths with facts — and acting on those facts consistently.